Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (181-190 of 487) with videos related to

Pageof 49
Sort By:
Cancers|March 22, 2020
Cancer Genetics and Therapeutic Opportunities in Urologic PracticeJacob J Adashek, Alex Leonard, Jason Roszik, et al.
Molecular Cancer Therapeutics|April 12, 2022
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant TumorsJacob J Adashek, Arjun K Menta, Neha K Reddy, et al.
Oncoscience|September 22, 2023
Activity of pazopanib in <i>EWSR1-NFATC2</i> translocation-associated bone sarcomaMohamed A Gouda, Maria A Zarzour, Ara A Vaporciyan, et al.
Oncotarget|January 8, 2014
A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphomaVivek Subbiah, Robert E Brown, Mary F McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedsideVivek Subbiah, John Slopis, David S Hong, et al.
Molecular Cancer Therapeutics|September 8, 2021
Hallmarks of RET and Co-occuring Genomic Alterations in <i>RET</i>-aberrant CancersJacob J Adashek, Aakash P Desai, Alexander Y Andreev-Drakhlin, et al.
Plos One|August 8, 2013
Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1)Vivek Subbiah, Robert E Brown, Yunyun Jiang, et al.
Thyroid Research|August 13, 2023
Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods studySuzanne Murray, Vivek Subbiah, Steven I Sherman, et al.
Med (New York, N.Y.)|January 29, 2026
Precision oncology in rare tumors: Have the orphans been adopted?Hiba Mechahougui, Alex Friedlaender, Kıvanç Görgülü, et al.
ESMO Open|April 10, 2019
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCISTKalevi Kairemo, Eric M Rohren, Pete M Anderson, et al.
Pageof 49

Showing results (181-190 of 487) with videos related to

Sort By:
Pageof 49
Cancers|March 22, 2020
Cancer Genetics and Therapeutic Opportunities in Urologic PracticeJacob J Adashek, Alex Leonard, Jason Roszik, et al.
Molecular Cancer Therapeutics|April 12, 2022
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant TumorsJacob J Adashek, Arjun K Menta, Neha K Reddy, et al.
Oncoscience|September 22, 2023
Activity of pazopanib in <i>EWSR1-NFATC2</i> translocation-associated bone sarcomaMohamed A Gouda, Maria A Zarzour, Ara A Vaporciyan, et al.
Oncotarget|January 8, 2014
A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphomaVivek Subbiah, Robert E Brown, Mary F McGuire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedsideVivek Subbiah, John Slopis, David S Hong, et al.
Molecular Cancer Therapeutics|September 8, 2021
Hallmarks of RET and Co-occuring Genomic Alterations in <i>RET</i>-aberrant CancersJacob J Adashek, Aakash P Desai, Alexander Y Andreev-Drakhlin, et al.
Plos One|August 8, 2013
Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1)Vivek Subbiah, Robert E Brown, Yunyun Jiang, et al.
Thyroid Research|August 13, 2023
Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods studySuzanne Murray, Vivek Subbiah, Steven I Sherman, et al.
Med (New York, N.Y.)|January 29, 2026
Precision oncology in rare tumors: Have the orphans been adopted?Hiba Mechahougui, Alex Friedlaender, Kıvanç Görgülü, et al.
ESMO Open|April 10, 2019
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCISTKalevi Kairemo, Eric M Rohren, Pete M Anderson, et al.
Pageof 49